HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 23, 16860-16870, June 8, 2007

This Article Full Text Full Text (PDF) All Versions of this Article: 282/23/16860    most recent M610943200v2 M610943200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luan, Y. Articles by Liu, C.-j. Search for Related Content PubMed PubMed Citation Articles by Luan, Y. Articles by Liu, C.-j. Social Bookmarking                      What's this?

The Retinoblastoma Protein Is an Essential Mediator of Osteogenesis That Links the p204 Protein to the Cbfa1 Transcription Factor Thereby Increasing Its Activity^*

Yi Luan, Xiu-Ping Yu, Ke Xu, Bo Ding^¶, Jin Yu^¶, Yan Huang^||, Ning Yang, Peter Lengyel^¶, Paul E. Di Cesare^**, and Chuan-ju Liu¹

From the Department of Orthopedic Surgery, New York University Medical Center, New York, New York 10003, the Institute of Pathogenic Biology, Shandong University School of Medicine, Jinan, Shandong 250012, China, the Departments of ^¶Molecular Biophysics and Biochemistry and ^||Internal Medicine and Cardiology, Yale University School of Medicine, New Haven, Connecticut 06520-8024, the ^**Department of Orthopedic Surgery, University of California Davis Medical Center, Davis, California 95817, and the Department of Cell Biology, New York University School of Medicine, New York, New York 10016

Bone formation requires the coordinated activity of numerous proteins including the transcription factor core-binding factor 1 (Cbfa1). Deregulation of Cbfa1 results in metabolic bone diseases including osteoporosis and osteopetrosis. The retinoblastoma protein (pRb) that is required for osteogenesis binds Cbfa1. We reported earlier that the p200 family protein p204, which is known to be involved in the differentiation of skeletal muscle myotubes, cardiac myocytes, and macrophages, also serves as a cofactor of Cbfa1 and promotes osteogenesis. In this study we established that suppression of p204 expression by an adenovirus construct encoding p204 antisense RNA inhibited osteoblast-specific gene activation by Cbfa1 in an osteogenesis assay involving the pluripotent C2C12 mesenchymal cell line. Using protein-protein interaction assays we established that Cbfa1, pRb, and p204 form a ternary complex in which pRb serves as a linker connecting p204 and Cbfa1. Chromatin immunoprecipitation assays revealed the binding of such a p204-pRb-Cbfa1 transcription factor complex to the promoter of the osteocalcin gene. The pRb requirement of the stimulation of Cbfa1 activity by p204 was established in experiments involving p204 mutants lacking one or two pRb binding (LXCXE) motifs. Such mutants failed to enhance the Cbfa1-dependent transactivation of gene expression as well as osteogenesis. Furthermore, as revealed in reporter gene and in vitro osteogenesis assays p204 synergized with pRb in the stimulation of Cbfa1-dependent gene activation and osteoblast differentiation.

Received for publication, November 28, 2006 , and in revised form, April 16, 2007.

^* This work was supported by National Institutes of Health Research Grants AR050620 (to C. J. L.), AR052022 (to C. J. L.), and AI-12320 (to P. L.) and a New York Chapter of the Arthritis Foundation Dorothy W. Goldstein Young Scholar Award (to C. J. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom correspondence should be addressed: Rm. 1608, HJD, Dept. of Orthopedic Surgery, 301 E. 17th St., New York University Medical Center, New York, NY 10003. Tel.: 212-598-6103; Fax: 212-598-6096; E-mail: chuanju.liu{at}med.nyu.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. A. Lin, L. Kong, X.-H. Bai, Y. Luan, and C.-j. Liu miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1 J. Biol. Chem., April 24, 2009; 284(17): 11326 - 11335. [Abstract] [Full Text] [PDF]

				S. D. Berman, T. L. Yuan, E. S. Miller, E. Y. Lee, A. Caron, and J. A. Lees The Retinoblastoma Protein Tumor Suppressor Is Important for Appropriate Osteoblast Differentiation and Bone Development Mol. Cancer Res., September 1, 2008; 6(9): 1440 - 1451. [Abstract] [Full Text] [PDF]

				Y. Arima, Y. Inoue, T. Shibata, H. Hayashi, O. Nagano, H. Saya, and Y. Taya Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition Cancer Res., July 1, 2008; 68(13): 5104 - 5112. [Abstract] [Full Text] [PDF]

				Y. Luan, X.-P. Yu, N. Yang, S. Frenkel, L. Chen, and C.-j. Liu p204 Protein Overcomes the Inhibition of Core Binding Factor {alpha}-1-mediated Osteogenic Differentiation by Id Helix-Loop-Helix Proteins Mol. Biol. Cell, May 1, 2008; 19(5): 2113 - 2126. [Abstract] [Full Text] [PDF]

				B. Ding and P. Lengyel p204 Protein Is a Novel Modulator of Ras Activity J. Biol. Chem., February 29, 2008; 283(9): 5831 - 5848. [Abstract] [Full Text] [PDF]